Header Logo

Connection

JACOB MANDEL to Humans

Back to Details
This is a "connection" page, showing publications JACOB MANDEL has written about Humans.
JACOB MANDEL
Connection Strength
0.391
Humans
  1. External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma. JAMA Oncol. 2023 07 01; 9(7):1006.
    View in: PubMed
    Score: 0.022
  2. Varied histomorphology and clinical outcomes of FGFR3-TACC3 fusion gliomas. Neurosurg Focus. 2022 12; 53(6):E16.
    View in: PubMed
    Score: 0.021
  3. Hypertrophic Olivary Degeneration Postoperatively Following Pilocytic Astrocytoma Resection. World Neurosurg. 2022 09; 165:18-19.
    View in: PubMed
    Score: 0.021
  4. IDH mutation status and the development of venous thromboembolism in astrocytoma patients. J Neurol Sci. 2021 Aug 15; 427:117538.
    View in: PubMed
    Score: 0.019
  5. Hyperostosis frontalis interna diagnosed after a provoked seizure. BMJ Case Rep. 2020 Jul 01; 13(7).
    View in: PubMed
    Score: 0.018
  6. Recurrent Papillary Glioneuronal Tumor. World Neurosurg. 2019 Aug; 128:127-130.
    View in: PubMed
    Score: 0.017
  7. Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol. 2019 Apr; 142(2):365-374.
    View in: PubMed
    Score: 0.016
  8. Highlighting the need for reliable clinical trials in glioblastoma. Expert Rev Anticancer Ther. 2018 10; 18(10):1031-1040.
    View in: PubMed
    Score: 0.016
  9. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 2018 01 10; 20(1):113-122.
    View in: PubMed
    Score: 0.015
  10. Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis. J Neurol Sci. 2016 Oct 15; 369:51-52.
    View in: PubMed
    Score: 0.014
  11. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
    View in: PubMed
    Score: 0.014
  12. Intracranial epithelioid hemangioendothelioma causing subacute loss of vision. Neurology. 2015 Aug 25; 85(8):735-6.
    View in: PubMed
    Score: 0.013
  13. Delayed imaging abnormalities of neuro-invasive West Nile virus in cancer patients. J Neurol Sci. 2015 Mar 15; 350(1-2):115-7.
    View in: PubMed
    Score: 0.012
  14. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
    View in: PubMed
    Score: 0.012
  15. Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
    View in: PubMed
    Score: 0.012
  16. Update on anti-angiogenic treatment for malignant gliomas. Curr Oncol Rep. 2014 Apr; 16(4):380.
    View in: PubMed
    Score: 0.012
  17. Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge. Nat Commun. 2025 Jul 08; 16(1):6274.
    View in: PubMed
    Score: 0.006
  18. Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 01 16; 13(1):9.
    View in: PubMed
    Score: 0.006
  19. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors. J Neurooncol. 2024 Apr; 167(2):349-359.
    View in: PubMed
    Score: 0.006
  20. Aggressive human MenG C meningiomas have a molecular counterpart in canines. Acta Neuropathol. 2024 02 20; 147(1):42.
    View in: PubMed
    Score: 0.006
  21. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
    View in: PubMed
    Score: 0.005
  22. Federated learning enables big data for rare cancer boundary detection. Nat Commun. 2022 12 05; 13(1):7346.
    View in: PubMed
    Score: 0.005
  23. EWSR1-PATZ1 Fusion Gene in Ependymoma: A Report of Two Adult Cases and Systematic Review of Literature. JCO Precis Oncol. 2022 12; 6:e2200312.
    View in: PubMed
    Score: 0.005
  24. Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on management. J Neurol Sci. 2022 07 15; 438:120291.
    View in: PubMed
    Score: 0.005
  25. Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study. Neurosurgery. 2022 01 01; 90(1):114-123.
    View in: PubMed
    Score: 0.005
  26. Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects. Neuro Oncol. 2021 08 02; 23(8):1383-1392.
    View in: PubMed
    Score: 0.005
  27. The concurrence of multiple sclerosis and glioblastoma. Mult Scler Relat Disord. 2021 May; 50:102877.
    View in: PubMed
    Score: 0.005
  28. Intracranial Solitary Fibrous Tumor of the Skull Base: 2 Cases and Systematic Review of the Literature. World Neurosurg. 2021 05; 149:e345-e359.
    View in: PubMed
    Score: 0.005
  29. Multicentric non-enhancing lesions in glioblastoma: A retrospective study. J Clin Neurosci. 2021 Mar; 85:20-26.
    View in: PubMed
    Score: 0.005
  30. Height as a risk factor in meningioma: a study of 2 million Israeli adolescents. BMC Cancer. 2020 Aug 20; 20(1):786.
    View in: PubMed
    Score: 0.005
  31. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
    View in: PubMed
    Score: 0.004
  32. Exclusion of patients with brain metastases from cancer clinical trials. Neuro Oncol. 2020 04 15; 22(4):577-579.
    View in: PubMed
    Score: 0.004
  33. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. JAMA Oncol. 2019 12 01; 5(12):1769-1773.
    View in: PubMed
    Score: 0.004
  34. Gastrointestinal stromal tumor with intracranial metastasis: case presentation and systematic review of literature. BMC Cancer. 2019 Nov 15; 19(1):1119.
    View in: PubMed
    Score: 0.004
  35. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol. 2020 04; 11(3):451-454.
    View in: PubMed
    Score: 0.004
  36. Treatment strategies for glioblastoma in older patients: age is just a number. J Neurooncol. 2019 Nov; 145(2):357-364.
    View in: PubMed
    Score: 0.004
  37. Newly Diagnosed Optic Pathway Glioma During Pregnancy. World Neurosurg. 2019 Jul; 127:58-62.
    View in: PubMed
    Score: 0.004
  38. Disparities along the glioblastoma clinical trials landscape. Neuro Oncol. 2019 02 14; 21(2):285-286.
    View in: PubMed
    Score: 0.004
  39. Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018 May; 137(3):601-609.
    View in: PubMed
    Score: 0.004
  40. Spinal Dural Arteriovenous Fistula and Concomitant Intramedullary Spinal Lesion. Can J Neurol Sci. 2018 03; 45(2):238-239.
    View in: PubMed
    Score: 0.004
  41. Intracranial Erdheim-Chester Disease Mimicking Parafalcine Meningioma: Report of Two Cases and Review of the Literature. World Neurosurg. 2018 Feb; 110:365-370.
    View in: PubMed
    Score: 0.004
  42. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
    View in: PubMed
    Score: 0.004
  43. Intraventricular Cavernomas of the Third Ventricle: Report of 2 Cases and a Systematic Review of the Literature. World Neurosurg. 2017 Sep; 105:935-943.e3.
    View in: PubMed
    Score: 0.004
  44. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.003
  45. Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
    View in: PubMed
    Score: 0.003
  46. Venous thromboembolism (VTE) and glioblastoma. J Neurooncol. 2015 Aug; 124(1):87-94.
    View in: PubMed
    Score: 0.003
  47. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.